Moyamoya disease is a progressive cerebrovascular disorder characterized by bilateral stenosis of the internal carotid arteries and compensatory formation of a fragile collateral vessel network ("puff of smoke"). Presenting with TIA, ischemic stroke, or cerebral hemorrhage, management combines catheter angiography, antiplatelet therapy, and direct or indirect revascularization surgery.
Moyamoya disease is a rare neurological condition characterized by progressive stenosis (narrowing) of the main arteries supplying the brain, particularly the internal carotid arteries, leading to the formation of collateral vessels as a compensatory mechanism. The term "Moyamoya" is of Japanese origin, meaning "puff of smoke." This term refers to the characteristic appearance of the brain’s blood vessels on angiography, where the narrowed arteries are surrounded by a network of small, thin, and inadequate new vessels that resemble a "smoke-like" cloud. These collateral vessels are often insufficient in providing adequate blood flow to the brain, resulting in cerebral ischemia, strokes, transient ischemic attacks (TIAs), and other neurological deficits.
Moyamoya Disease Symptoms
Moyamoya disease often presents with a range of neurological symptoms, which are primarily due to reduced cerebral perfusion and focal tissue ischemia:
- Headaches: Patients frequently experience recurrent, throbbing or pulsating headaches associated with dizziness or lightheadedness due to cerebral hypoperfusion.
- Strokes and TIAs: Sudden onset of neurological deficits such as hemiparesis, facial drooping, dysphasia, or limb weakness. Ischemic strokes in Moyamoya disease may produce lasting motor and cognitive impairments.
- Seizures: Chronic disruption of cortical blood flow can trigger abnormal electrical activity in the brain, resulting in focal or generalized seizures.
- Cognitive and Mental Disorders: Memory impairment, executive dysfunction, and learning difficulties can develop secondary to chronic ischemic damage in cognitive brain regions.
- Motor Dysfunction: Impaired motor control leading to movement difficulties, gait instability, and balance impairments.
Moyamoya Disease Diagnosis
The diagnosis of Moyamoya disease is primarily based on neuroimaging techniques that visualize arterial stenosis, collateral network formation, and brain perfusion status:
Magnetic Resonance Imaging (MRI) & Perfusion
The baseline imaging modality used to evaluate areas of acute or chronic ischemic damage, watershed infarcts, and structural brain parenchymal changes.
MR Angiography (MRA)
Non-invasively depicts the stenosis of the supraclinoid internal carotid arteries and proximal circle of Willis, demonstrating initial collateral vessel networks for diagnostic screening.
CT Angiography (CTA)
Provides high-resolution multiplanar 3D images of intracranial vascular anatomy, assisting in rapid stenosis evaluation and ruling out coexisting vascular anomalies.
Catheter Digital Subtraction Angiography (DSA)
Considered the gold standard for definitive diagnosis and surgical planning. Allows detailed visualization of arterial narrowing, leptomeningeal collaterals, transdural anastomoses, and the classic "puff of smoke" phenomenon.
Moyamoya Disease Treatment Methods
The management of Moyamoya disease primarily aims to improve cerebral blood flow, prevent recurrent ischemic or hemorrhagic strokes, and manage neurological symptoms through surgical and medical modalities:
1. Surgical Revascularization (Bypass Surgery)
Surgical bypass is the definitive treatment to restore cerebral perfusion:
- Direct Revascularization: A donor scalp artery (such as the superficial temporal artery) is micro-surgically anastomosed directly to a recipient cortical artery (STA-MCA bypass) to provide immediate blood flow augmentation.
- Indirect Revascularization: Vascularized tissues (dura mater, temporal muscle, or galeal flap) are placed onto the cerebral cortex (e.g., EDAS or EDAM) to stimulate neo-angiogenesis and spontaneous collateral growth over time.
2. Endovascular Intervention
In selective clinical scenarios, endovascular techniques such as intracranial angioplasty or stenting may be considered to widen localized arterial stenosis, though surgical revascularization remains the mainstay of care.
3. Pharmacological Management
Antiplatelet agents are routinely prescribed to reduce ischemic stroke risk, while anticonvulsants manage seizure activity. Medical therapy serves as an adjunct to surgical revascularization.
4. Long-Term Follow-up & Surveillance
Regular clinical evaluations and serial neuroimaging (MRA, CTA, or catheter DSA) are necessary to monitor disease progression, bypass patency, and collateral development.
Frequently Asked Questions
What is Moyamoya disease?
Moyamoya disease is a progressive cerebrovascular condition caused by narrowing of the main arteries at the base of the brain, leading to a compensatory "puff of smoke" network of tiny collateral blood vessels.
What does "Moyamoya" mean?
It is a Japanese term meaning "puff of smoke," describing the characteristic cloud-like appearance of tiny collateral blood vessels seen on brain angiography.
What are the main symptoms of Moyamoya disease?
Key symptoms include transient ischemic attacks (TIAs), ischemic or hemorrhagic strokes, recurrent headaches, seizures, motor weakness, and cognitive decline.
How is Moyamoya disease diagnosed?
Diagnosis is established using MRI, MRA, CTA, and catheter Digital Subtraction Angiography (DSA), which serves as the gold standard for vascular evaluation.
What is surgical revascularization for Moyamoya disease?
It is a surgical procedure (direct STA-MCA bypass or indirect EDAS/dural inversion) designed to restore blood flow to ischemic brain tissue by diverting scalp blood vessels or tissue to the brain surface.
Can Moyamoya disease be cured with medication alone?
No. Medications like antiplatelets help manage stroke risk, but surgical revascularization is the only effective treatment to directly restore brain perfusion and stop disease progression.